Fludarabine, busulfan, and thiotepa may be a promising conditioning regimen for myelofibrosis patients undergoing allogeneic stem cell transplantation

被引：0
|
作者：
Shouval, Roni [1 ]
Vega, Yakov [1 ]
Fein, Joshua A. [1 ]
Danylesko, Ivetta [1 ]
Tov, Noga Shem [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
Shimoni, Avichai [1 ]
机构：
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Hematol & Bone Marrow Transplantat, Ramat Gan, Israel
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P096
引用
收藏
页码：204 / 205
页数：2
相关论文
共 50 条
  • [31] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [32] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [33] Busulfan-fludarabine versus thiotepa-fludarabine as a reduced-intensity preparative regimen for allogeneic haematopoietic stem-cell transplantation in patients with myelofibrosis: A phase II, multicentre, randomized trial
    Patriarca, F.
    Masciulli, A.
    Bacigalupo, A.
    Pavoni, C.
    Finazzi, M. C.
    Bosi, A.
    Russo, D.
    Narni, F.
    Messina, G.
    Alessandrino, E. P.
    Cascavilla, N.
    Pisapia, G.
    Immovilli, A.
    Milone, G.
    Bruno, B.
    Mammoliti, S.
    Bruno, B.
    Fanin, R.
    Bonifazi, F.
    Rambaldi, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S421 - S422
  • [34] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547
  • [35] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    M Iravani
    M R Evazi
    S A Mousavi
    A R Shamshiri
    M Tavakoli
    A Ashouri
    S Samiee
    B Chahardovali
    K Alimoghaddam
    S H Ghaffari
    A Ghavamzadeh
    Bone Marrow Transplantation, 2007, 40 : 105 - 110
  • [36] Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning
    Manna, Mita
    Daly, Andrew
    Kangarloo, Bill
    Savoie, Mary Lynn
    Storek, Jan
    BLOOD, 2015, 126 (23)
  • [37] Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies
    El Darsa, Haidar
    Massoud, Radwan
    Zahreddine, Ammar
    Bazarbachi, Ali
    El-Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S390 - S391
  • [38] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    E P Alessandrino
    P Bernasconi
    A A Colombo
    D Caldera
    L Malcovati
    D Troletti
    L Vanelli
    M Varettoni
    F Montanari
    M Lazzarino
    Bone Marrow Transplantation, 2004, 34 : 1039 - 1045
  • [39] Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies
    El Darsa, Haidar
    Massoud, Radwan
    Haffar, Basel
    Zaherddine, Ammar
    Bazarbachi, Ali
    Elcheikh, Jean
    BLOOD, 2017, 130
  • [40] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Troletti, D
    Vanelli, L
    Varettoni, M
    Montanari, F
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1039 - 1045
12345